Exploring New and Global Therapeutic Options for Dry Eye Disease: What You Need to Know
- 7 March 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Eye & Contact Lens: Science & Clinical Practice
- Vol. 51 (7) , 312-317
Abstract
Dry eye disease (DED) is a complex condition characterized by the loss of tear film homeostasis, resulting in ocular symptoms, inflammation, and damage. Managing DED involves a diverse range of therapies aimed at alleviating symptoms and addressing underlying causes. This review provides a comprehensive update on current DED treatments, focusing on medications approved by the United States (US) Food and Drug Administration and notable treatments available outside the United States. Differences in treatment approaches between Asian and Western countries have been explored, highlighting the need for a nuanced understanding of regional variations. The Asia Dry Eye Society offers a new perspective on dry eye, further elucidating these regional distinctions. This review emphasizes the importance of staying informed about evolving treatment guidelines and advancements in DED therapeutics. As the field progresses with new and innovative therapies, there is increased potential for improved patient management and enhanced quality of life for individuals affected by DED.Keywords
This publication has 24 references indexed in Scilit:
- NOV03 for Dry Eye Disease Associated with Meibomian Gland DysfunctionOphthalmology, 2022
- Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye DiseaseOphthalmology, 2022
- A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye DiseaseOphthalmology, 2019
- A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye DiseaseOphthalmology, 2019
- Classification of Fluorescein Breakup Patterns: A Novel Method of Differential Diagnosis for Dry EyeAmerican Journal of Ophthalmology, 2017
- TFOS DEWS II Definition and Classification ReportThe Ocular Surface, 2017
- TFOS DEWS II Diagnostic Methodology reportThe Ocular Surface, 2017
- New Perspectives on Dry Eye Definition and Diagnosis: A Consensus Report by the Asia Dry Eye SocietyThe Ocular Surface, 2017
- Lifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye DiseaseOphthalmology, 2014
- Long-term Resolution of Chronic Dry Eye Symptoms and Signs after Topical Cyclosporine TreatmentOphthalmology, 2007